Lior Rennert1, Corey Andrew Kalbaugh2, Lu Shi2, Christopher McMahan3. 1. Public Health Sciences, Clemson University, Clemson, South Carolina, USA liorr@clemson.edu. 2. Public Health Sciences, Clemson University, Clemson, South Carolina, USA. 3. Mathematical and Statistical Sciences, Clemson University, Clemson, South Carolina, USA.
This modelling study informs universities about the impact of pre-semester testing on COVID-19 spread.We evaluate the impact of presemester testing on the number of active COVID-19 cases at the semester start.Using dynamic transmission models, we also evaluate the impact of presemester testing strategies on the number of active infections throughout the semester and on time until isolation bed capacity is reached.Our model parameters are informed by the current literature on SARS-CoV-2 transmission dynamics.A limitation of our study is that results are dependent on model input parameters. Therefore, we created a user-friendly web-based application to provide model projections on up-to-date parameters when they become available.
Introduction
Universities in the USA are currently exploring strategies to mitigate the spread of COVID-19 prior to reopening their campuses. Between dormitories, classrooms and nightlife, university campuses present an ideal environment for viral spread and are therefore at extreme risk of serving as a hotbed for a COVID-19 outbreak. This has been the recent experience of several universities in the USA.1 Many universities have widespread testing capabilities, contact tracing and reserved spaces to isolate detected cases, which are well-known strategies for controlling COVID-19 in the absence of a vaccine.2–5 Recent modelling studies found that widespread testing of the entire student population once per month was sufficient for detecting an outbreak of fewer than nine individuals,4 and small outbreaks could be contained with highly effective contact tracing and case isolation.5However, these strategies may not be sufficient for curtailing a larger outbreak should one occur. This is primarily due to the number of daily high-density social events, especially during the first few weeks of the semester, that occur on and off campus.6–8 These events lead to a high number of close-encounter contacts per student and thus provides a perfect path for viral transmission. Because cases are not detected immediately, it will be virtually impossible to trace all close-encounter contacts of infected individuals. A recent study concluded that contact tracing and isolation are likely ineffective in controlling outbreaks if the number of initial cases is 40 or greater.5 Given the difficulties of timely contact tracing in the university setting, it is of utmost importance to limit the initial number of active cases at the start of the semester. One method of doing so is through student testing prior to campus return.There are differing views as to whether universities should test all students for COVID-19 prior to campus arrival. While some public officials stress the need to test in order to contain the spread of the virus, others cite the costs and false negatives of tests as reasons to limit testing and isolation to symptomatic students on their return to campus.9 Currently, the Center for Disease Control and Prevention (CDC) does not overtly endorse, nor recommend against, testing the entire student population prior to campus arrival.10However, the impact of presemester testing strategies have not been previously studied.10Our team was tasked with recommending strategies for baseline testing and isolation bed capacity to be used in moving a large university in the Southeastern USA towards reopening in Fall 2020 amidst the ongoing COVID-19 pandemic. We considered several testing strategies: (1) No screening of students prior to the fall semester, (2) requiring all students to present a negative test (via a nucleic acid amplification test, NAT) within 1 week of arrival and (3) requiring all students to present two negative NAT tests within 1 week of arrival on campus.
Methods
To guide and inform our recommendations, we implemented a two-population (on and off campus) dynamic transmission model11 of SARS-CoV-2 infection under each testing strategy to determine the number of active infections and the days until the maximum isolation bed occupancy is reached. The latter could be viewed as a potential ‘trigger’ that would initiate moving the university online, since a lack of isolation beds will force universities to allow infectious individuals to live among susceptible students. This would substantially increase the risk of disease transmission and would violate current CDC guidelines.12 The model includes the following compartments: S, E, I1, I2, H, R, where S is the number of susceptible individuals (ie, those who have not yet been infected), E is the number of individuals who are exposed but not yet infectious, I1 is the number of asymptomatic or undetected infected individuals, I2 is the number of symptomatic and detected infected individuals, H is the number of individuals requiring housing for isolation and R is the number of recovered individuals. Additional model detail is provided in online supplemental table 1.Table 1 presents the percentage of active cases at the beginning of the semester for each testing strategy for a population of N=25 000, assuming different levels of active infection rates in the student population. We assume an initial active infection rate of 2% for the transmission model. This is based on a sample of students moving into residence halls and campus apartments at the University of Iowa.13 We assume that 10%4 of students will have already had the disease and recovered by the start of the semester. For each testing strategy, the number of infected individuals on campus at the start of the semester is provided in the second row of table 1. In the models below, we also assume a student population of 25 000, with an on-campus population of 7500 and an off-campus population of 17 500. We specify the maximum occupancy of isolation beds to be 2% of the student population. For a university with a student population of 25 000, this is equivalent to 500 isolation beds. We assume that students remain in isolation for 11 days, which represents the median time until a negative NAT test.14 We assume that 50% of infections are symptomatic,15 but only two out of three symptomatic students will be detected and isolate. Thus, we implicitly assume that one-third of all infected students are detected and require an isolation bed.
Table 1
Percentage (and expected number) of active cases under different initial active infection rates and testing strategies
% infectious at beginning of semester
% of student population infectious on campus for each testing strategy (expected no of active cases on campus for N=25 000)
No testing
One NAT test
Two NAT tests
1%
1 (225 cases)
0.1 (23 cases)
0.01 (2 cases)
2%
2 (450 cases)
0.2 (45 cases)
0.02 (5 cases)
5%
5 (1125 cases)
0.5 (113 cases)
0.05 (11 cases)
10%
10 (2250 cases)
1 (225 cases)
0.1 (23 cases)
The (expected) number of active cases are based on a university of size N=25 000 and assumes that 10% of the population is immune (eg, through previous disease exposure). NAT test sensitivity is set at through previous disease exposure). NAT test sensitivity is set at 90%.
NAT, nucleic acid amplification test.
Percentage (and expected number) of active cases under different initial active infection rates and testing strategiesThe (expected) number of active cases are based on a university of size N=25 000 and assumes that 10% of the population is immune (eg, through previous disease exposure). NAT test sensitivity is set at through previous disease exposure). NAT test sensitivity is set at 90%.NAT, nucleic acid amplification test.We vary the level of R0 between 1.5, 2, 3 and 4 to represent the effectiveness of mitigation strategies throughout the semester. The lower values of R0 imply a reduced contact rate between students and reflect effective mitigation strategies, such as frequent testing, successful contact tracing and isolation of suspected and confirmed cases, enforcement of social distancing, mask mandates, etc. The CDC estimates R0 in the range of 2–4.16 Additional parameters for our model are based on the published literature and are provided in online supplemental table 2.4 13–21 We have developed a user-friendly application that allows the user to vary the parameters of this model. This application is available at the following website: https://rennertl.shinyapps.io/PresemesterTesting/. The R code generating this application is available as an online supplemental file.
Patient and public involvement
No patients or the public were involved in the development of research questions, study design, writing, interpretation or dissemination of the results.
Results
The results of the modelling study are presented in figure 1. If no presemester screening is mandated, the timing of the peak number of active infections occurs between 24 days (R0=4) and 50 days (R0=1.5). The size of the peak is substantial, ranging from 4114 active infections when effective mitigation strategies are implemented (R0=1.5) to 10 481 active infections for less effective strategies (R=4). Furthermore, no presemester screening exhausts isolation bed capacity within 10 days (R0=4) to 25 days (R0=1.5).
Figure 1
Expected number of active infections over time under three presemester testing strategies: no NAT tests (solid red line), 1 NAT test (dashed blue line), 2 NAT tests (dotted green line). assuming one-third of infected students require an isolation bed, and an availability of 500 isolation beds. Days to trigger represents the time (days) until isolation bed capacity is reached. NAT, nucleic acid amplification test.
Expected number of active infections over time under three presemester testing strategies: no NAT tests (solid red line), 1 NAT test (dashed blue line), 2 NAT tests (dotted green line). assuming one-third of infected students require an isolation bed, and an availability of 500 isolation beds. Days to trigger represents the time (days) until isolation bed capacity is reached. NAT, nucleic acid amplification test.Requiring at least one NAT test within 1 week of campus arrival delays the timing of the peak number of active infections and the corresponding time until isolation bed occupancy is reached. The advantages of presemester screening are especially noteworthy when implemented in conjunction with effective mitigation strategies (as indicated by the lower values of R0). When one NAT test is mandated within 1 week of campus arrival, effective (R0=1.5) and less effective (R0=4) mitigation strategies delay the onset of the peak to 86 days and 34 days, respectively, and result in a peak size ranging from 3794 to 10 325 active infections. When two NAT tests are mandated, effective (R0=1.5) and less effective (R0=4) mitigation strategies delay the onset of the peak through the end of fall semester and 45 days, respectively, and result in peak size ranging from 1790 to 10 310 active infections.However, unless university mitigation strategies are indeed effective, maximum isolation bed occupancy is reached quickly. If one out of three infections require isolation, then presemester screening alone will not maintain isolation bed occupancy below the maximum threshold in most settings. Presemester screening using one NAT test exhausts isolation bed capacity within 20 days (R0=4) to 60 days (R0=1.5). Presemester screening using two NAT tests maintains isolation bed capacity through the end of the semester if highly effective mitigation strategies are deployed (R=1.5). For less effective mitigation strategies, capacity will be exceeded between 31 days (R0=4) and 62 days (R0=2).
Discussion
The results of our study demonstrate that testing all students prior to campus arrival minimises the number of active infections at the semester start, reduces the size of the peak outbreak, and delays both the time of the peak and the time until isolation bed capacity is reached. Detection of active cases prior to campus arrival is therefore essential to ensuring that a rapid spike of cases does not occur at the beginning of the semester; a failure to do so can result in bringing anywhere from hundreds to thousands of infectious cases onto campus. Limiting screening to symptomatic students may not be sufficient, as many students may be presymptomatic or asymptomatic, and can unknowingly facilitate disease spread. Ideally, given the biology of the virus and the operating characteristics of the various NAT tests available for COVID-19, we believe that each student should be tested twice to minimise the risk of false negatives.22Our team has specifically recommended that each student be tested (via NAT) within 1 week of campus return and on return to campus. We note that institutions may choose to implement alternative testing for SARS-CoV-2 as they become established.23 For example, saliva-based tests may provide a faster, cheaper and less invasive alternative to nasal swab testing, without compromising test sensitivity.24 However, even with presemester screening, highly effective mitigation strategies are needed to avoid a large surge in cases.Given the recent surge of COVID-1925 and that vaccination will unlikely be available to students and institutional employees before 2021,26 implementation of prearrival testing will still be relevant for the Spring 2021 semester. Our recommendations for prearrival testing are indeed relevant for both future waves of the COVID-19 pandemic and future pandemics. Furthermore, prearrival testing is applicable to any institution (eg, schools, workforce, etc) returning individuals to high-density environments that are conducive to disease spread.
Strengths and limitations
Our study is the first to evaluate the impact of testing all students prior to their return to university campuses. A major strength of our study is that our models are guided by up-to-date disease transmission dynamics. However, information on these parameters may change with time, and may vary from institution to institution. We have, therefore, created a web application that allows the user to set the model parameters to reflect their institutional settings and/or to update parameters as more information becomes available (https://rennertl.shinyapps.io/PresemesterTesting/). The choices of these parameters may have a substantial impact on the timing and the size of the peak number of active infections. For example, longer infectious periods and a lower proportion of the population that is immune at the semester start correspond to earlier and larger peaks, while an increase in the time spent in isolation decreases the time until isolation bed capacity is reached. More robust data on these parameters and test sensitivity, disease prevalence at the onset of the semester, and the impact of mitigation strategies on disease spread would vastly improve these estimates by minimising uncertainty.One limitation of our model is that it exclusively focuses on the student population, whereas the disease transmission could very well occur between a student and a faculty/staff member of the university, who is on average older and more at risk for severe outcomes from contracting COVID-19. An outbreak within the university community could also influence the disease transmission pattern among local residents and vice versa. Future variants of our model could incorporate interactions between students, university faculty/staff and local residents around the university campus.There are also several logistical challenges to the proposed strategies discussed here. It remains unclear as to whether insurance providers will cover the costs of precautionary tests.27 Therefore, the financial burden may fall on the students or the university. In addition, single administration of a test could miss cases in the early stages of infection, as well as cases that occur in the days between administration of the test and campus arrival.10 For these reasons, a second NAT test has been recommended. However, this strategy amplifies the financial concerns and introduces additional logistical challenges. Universities may need to implement the second test on arrival on campus and thus need to ensure that proper resources are in place.10Another logistical challenge is the turn around time of the diagnostic tests. It has been noted that test turnaround time could be more important than test sensitivity in controlling this pandemic,28 and if the turnaround time is too long, then the follow-up isolation, quarantine and contact tracing will be infeasible. There has been serious concern about the bottleneck with testing services and the associated wait time for test results.29 However, with a series of point-of-care tests now authorised by the Food and Drug Administration and the congressionally funded RADx-Advanced Technologies Platforms programme to support 24 hours test turnaround time,30 there is reason to anticipate that the testing bottleneck will be less of a serious challenge for American colleges and universities in the coming months of the pandemic.
Conclusion
Detection of SARS-CoV-2 prior to campus arrival is necessary to avoid a large outbreak of hundreds to thousands of active infections at the onset of the semester. This is achievable through presemester screening via COVID-19 testing of the entire student population prior to campus arrival. While intensive presemester testing will delay the time of the peak outbreak and the time until isolation bed capacity is reached, such testing must be implemented in conjunction with highly effective mitigation strategies throughout the semester in order to substantially reduce outbreak size and preserve isolation bed capacity.
Authors: Bruce J Tromberg; Tara A Schwetz; Eliseo J Pérez-Stable; Richard J Hodes; Richard P Woychik; Rick A Bright; Rachael L Fleurence; Francis S Collins Journal: N Engl J Med Date: 2020-07-22 Impact factor: 91.245
Authors: Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo Journal: Lancet Glob Health Date: 2020-02-28 Impact factor: 26.763
Authors: Anne L Wyllie; John Fournier; Arnau Casanovas-Massana; Melissa Campbell; Maria Tokuyama; Pavithra Vijayakumar; Joshua L Warren; Bertie Geng; M Catherine Muenker; Adam J Moore; Chantal B F Vogels; Mary E Petrone; Isabel M Ott; Peiwen Lu; Arvind Venkataraman; Alice Lu-Culligan; Jonathan Klein; Rebecca Earnest; Michael Simonov; Rupak Datta; Ryan Handoko; Nida Naushad; Lorenzo R Sewanan; Jordan Valdez; Elizabeth B White; Sarah Lapidus; Chaney C Kalinich; Xiaodong Jiang; Daniel J Kim; Eriko Kudo; Melissa Linehan; Tianyang Mao; Miyu Moriyama; Ji E Oh; Annsea Park; Julio Silva; Eric Song; Takehiro Takahashi; Manabu Taura; Orr-El Weizman; Patrick Wong; Yexin Yang; Santos Bermejo; Camila D Odio; Saad B Omer; Charles S Dela Cruz; Shelli Farhadian; Richard A Martinello; Akiko Iwasaki; Nathan D Grubaugh; Albert I Ko Journal: N Engl J Med Date: 2020-08-28 Impact factor: 176.079
Authors: Christina N Morra; Sarah J Adkins-Jablonsky; M Elizabeth Barnes; Obadiah J Pirlo; Sloan E Almehmi; Bianca J Convers; Derek L Dang; Michael L Howell; Ryleigh Fleming; Samiksha A Raut Journal: Front Public Health Date: 2022-05-18
Authors: Diana Rose E Ranoa; Robin L Holland; Fadi G Alnaji; Kelsie J Green; Leyi Wang; Richard L Fredrickson; Tong Wang; George N Wong; Johnny Uelmen; Sergei Maslov; Zachary J Weiner; Alexei V Tkachenko; Hantao Zhang; Zhiru Liu; Ahmed Ibrahim; Sanjay J Patel; John M Paul; Nickolas P Vance; Joseph G Gulick; Sandeep Puthanveetil Satheesan; Isaac J Galvan; Andrew Miller; Joseph Grohens; Todd J Nelson; Mary P Stevens; P Mark Hennessy; Robert C Parker; Edward Santos; Charles Brackett; Julie D Steinman; Melvin R Fenner; Kirstin Dohrer; Michael DeLorenzo; Laura Wilhelm-Barr; Brian R Brauer; Catherine Best-Popescu; Gary Durack; Nathan Wetter; David M Kranz; Jessica Breitbarth; Charlie Simpson; Julie A Pryde; Robin N Kaler; Chris Harris; Allison C Vance; Jodi L Silotto; Mark Johnson; Enrique Andres Valera; Patricia K Anton; Lowa Mwilambwe; Stephen P Bryan; Deborah S Stone; Danita B Young; Wanda E Ward; John Lantz; John A Vozenilek; Rashid Bashir; Jeffrey S Moore; Mayank Garg; Julian C Cooper; Gillian Snyder; Michelle H Lore; Dustin L Yocum; Neal J Cohen; Jan E Novakofski; Melanie J Loots; Randy L Ballard; Mark Band; Kayla M Banks; Joseph D Barnes; Iuliana Bentea; Jessica Black; Jeremy Busch; Abigail Conte; Madison Conte; Michael Curry; Jennifer Eardley; April Edwards; Therese Eggett; Judes Fleurimont; Delaney Foster; Bruce W Fouke; Nicholas Gallagher; Nicole Gastala; Scott A Genung; Declan Glueck; Brittani Gray; Andrew Greta; Robert M Healy; Ashley Hetrick; Arianna A Holterman; Nahed Ismail; Ian Jasenof; Patrick Kelly; Aaron Kielbasa; Teresa Kiesel; Lorenzo M Kindle; Rhonda L Lipking; Yukari C Manabe; Jade Mayes; Reubin McGuffin; Kenton G McHenry; Agha Mirza; Jada Moseley; Heba H Mostafa; Melody Mumford; Kathleen Munoz; Arika D Murray; Moira Nolan; Nil A Parikh; Andrew Pekosz; Janna Pflugmacher; Janise M Phillips; Collin Pitts; Mark C Potter; James Quisenberry; Janelle Rear; Matthew L Robinson; Edith Rosillo; Leslie N Rye; MaryEllen Sherwood; Anna Simon; Jamie M Singson; Carly Skadden; Tina H Skelton; Charlie Smith; Mary Stech; Ryan Thomas; Matthew A Tomaszewski; Erika A Tyburski; Scott Vanwingerden; Evette Vlach; Ronald S Watkins; Karriem Watson; Karen C White; Timothy L Killeen; Robert J Jones; Andreas C Cangellaris; Susan A Martinis; Awais Vaid; Christopher B Brooke; Joseph T Walsh; Ahmed Elbanna; William C Sullivan; Rebecca L Smith; Nigel Goldenfeld; Timothy M Fan; Paul J Hergenrother; Martin D Burke Journal: Nat Commun Date: 2022-06-09 Impact factor: 17.694
Authors: Holly Blake; Sarah Somerset; Ikra Mahmood; Neelam Mahmood; Jessica Corner; Jonathan K Ball; Chris Denning Journal: Int J Environ Res Public Health Date: 2022-09-30 Impact factor: 4.614
Authors: Lior Rennert; Corey A Kalbaugh; Christopher McMahan; Lu Shi; Christopher C Colenda Journal: BMC Public Health Date: 2021-08-06 Impact factor: 3.295